Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 780

1.

Young-onset multiple system atrophy.

Jellinger KA.

Mov Disord. 2018 Dec;33(12):1974-1975. doi: 10.1002/mds.27567. No abstract available.

PMID:
30578693
2.

Different patterns of hippocampal tau pathology in Alzheimer's disease and PART.

Jellinger KA.

Acta Neuropathol. 2018 Nov;136(5):811-813. doi: 10.1007/s00401-018-1894-z. Epub 2018 Aug 7. No abstract available.

PMID:
30088091
3.

Very old onset parkinsonism: A clinical-pathological study.

Jellinger KA.

Parkinsonism Relat Disord. 2018 Dec;57:39-43. doi: 10.1016/j.parkreldis.2018.07.015. Epub 2018 Jul 24.

PMID:
30054179
4.

Is Braak staging valid for all types of Parkinson's disease?

Jellinger KA.

J Neural Transm (Vienna). 2018 Jun 25. doi: 10.1007/s00702-018-1898-9. [Epub ahead of print] Review.

PMID:
29943229
5.

Lateralisation in Parkinson disease.

Riederer P, Jellinger KA, Kolber P, Hipp G, Sian-Hülsmann J, Krüger R.

Cell Tissue Res. 2018 Jul;373(1):297-312. doi: 10.1007/s00441-018-2832-z. Epub 2018 Apr 14. Review.

PMID:
29656343
6.

Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Jellinger KA, Korczyn AD.

BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.

7.

Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases.

Attems J, Jellinger K.

Brain. 2018 Feb 1;141(2):329-331. doi: 10.1093/brain/awx360. No abstract available.

PMID:
29390123
8.

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.

Kaindlstorfer C, Jellinger KA, Eschlböck S, Stefanova N, Weiss G, Wenning GK.

J Alzheimers Dis. 2018;61(4):1253-1273. doi: 10.3233/JAD-170601. Review.

9.

Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Jellinger KA.

J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. Review.

PMID:
29222591
10.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27. Review.

PMID:
29076399
11.

Brain monoamine oxidases in human parkinsonian disorders.

Jellinger KA.

Brain. 2017 Sep 1;140(9):2262-2264. doi: 10.1093/brain/awx190. No abstract available.

PMID:
29050396
12.

Potential clinical utility of multiple system atrophy biomarkers.

Jellinger KA.

Expert Rev Neurother. 2017 Dec;17(12):1189-1208. doi: 10.1080/14737175.2017.1392239. Epub 2017 Oct 23. Review.

PMID:
29023182
13.

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Jellinger KA.

J Alzheimers Dis. 2018;62(3):1141-1179. doi: 10.3233/JAD-170397.

14.

Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

Jellinger KA.

Int Rev Neurobiol. 2017;133:13-62. doi: 10.1016/bs.irn.2017.05.005. Epub 2017 Jun 27. Review.

PMID:
28802920
15.

The diabetic brain and cognition.

Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, Dermanovic-Dobrota V, Grünblatt E, Jellinger KA, Kamal MA, Kamal W, Leszek J, Sheldrick-Michel TM, Mushtaq G, Meglic B, Natovich R, Pirtosek Z, Rakusa M, Salkovic-Petrisic M, Schmidt R, Schmitt A, Sridhar GR, Vécsei L, Wojszel ZB, Yaman H, Zhang ZG, Cukierman-Yaffe T.

J Neural Transm (Vienna). 2017 Nov;124(11):1431-1454. doi: 10.1007/s00702-017-1763-2. Epub 2017 Aug 1. Review.

PMID:
28766040
16.

Overlaps between multiple system atrophy and multiple sclerosis: A novel perspective.

Jellinger KA, Wenning GK.

Mov Disord. 2016 Dec;31(12):1767-1771. doi: 10.1002/mds.26870. Epub 2016 Nov 21. Review. No abstract available.

PMID:
27869324
17.

Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.

Laukoter S, Rauschka H, Tröscher AR, Köck U, Saji E, Jellinger K, Lassmann H, Bauer J.

Acta Neuropathol. 2017 Apr;133(4):613-627. doi: 10.1007/s00401-016-1642-1. Epub 2016 Nov 5.

18.

Vascular depression consensus report - a critical update.

Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O.

BMC Med. 2016 Nov 3;14(1):161.

19.

Post-mortem assessment in vascular dementia: advances and aspirations.

McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, Skrobot O, Taipa R, Thal DR, Werring D, Wharton SB, Attems J.

BMC Med. 2016 Aug 26;14(1):129. doi: 10.1186/s12916-016-0676-5. Review.

20.

Adolf Hitler and his parkinsonism.

Jellinger KA.

Ann Indian Acad Neurol. 2016 Jul-Sep;19(3):419. doi: 10.4103/0972-2327.186856. No abstract available.

21.

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.

Jellinger KA, Logroscino G, Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A.

Neurology. 2016 Jul 12;87(2):237-8. doi: 10.1212/WNL.0000000000002876. No abstract available.

PMID:
27402941
22.

Multiple system atrophy: pathogenic mechanisms and biomarkers.

Jellinger KA, Wenning GK.

J Neural Transm (Vienna). 2016 Jun;123(6):555-72. doi: 10.1007/s00702-016-1545-2. Epub 2016 Apr 20. Review.

PMID:
27098666
23.

Understanding Conflicting Neuropathological Findings.

Jellinger KA.

JAMA Neurol. 2016 Apr;73(4):479-80. doi: 10.1001/jamaneurol.2015.4879. No abstract available.

PMID:
26925877
24.

Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2015 Dec 28;4(2):49. eCollection 2015.

25.

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):87-102. doi: 10.1007/s00401-015-1509-x. Epub 2015 Dec 10. Review.

26.

How close are we to revealing the etiology of Parkinson's disease?

Jellinger KA.

Expert Rev Neurother. 2015 Oct;15(10):1105-7. doi: 10.1586/14737175.2015.1079486. Epub 2015 Aug 17. No abstract available.

PMID:
26294223
27.

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG.

Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15. Review.

PMID:
25982836
28.

Neuropathobiology of non-motor symptoms in Parkinson disease.

Jellinger KA.

J Neural Transm (Vienna). 2015 Oct;122(10):1429-40. doi: 10.1007/s00702-015-1405-5. Epub 2015 May 15. Review.

PMID:
25976432
29.

Olfaction and Aging: A Mini-Review.

Attems J, Walker L, Jellinger KA.

Gerontology. 2015;61(6):485-90. doi: 10.1159/000381619. Epub 2015 May 9. Review.

30.

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR Jr, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T.

Acta Neuropathol. 2015 May;129(5):757-62. doi: 10.1007/s00401-015-1407-2. Epub 2015 Mar 17. No abstract available.

31.

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J.

Acta Neuropathol. 2015 May;129(5):729-48. doi: 10.1007/s00401-015-1406-3. Epub 2015 Mar 11.

PMID:
25758940
32.

Diagnosis and differential diagnosis of MSA: boundary issues.

Kim HJ, Jeon BS, Jellinger KA.

J Neurol. 2015 Aug;262(8):1801-13. doi: 10.1007/s00415-015-7654-2. Epub 2015 Feb 7. Review.

PMID:
25663409
33.

Pathogenesis and treatment of vascular cognitive impairment.

Jellinger KA.

Neurodegener Dis Manag. 2014;4(6):471-90. doi: 10.2217/nmt.14.37. Review.

PMID:
25531689
34.

The cholinergic basal forebrain in Lewy body dementia and Alzheimer's disease.

Jellinger KA.

J Neurol. 2015 Feb;262(2):479-80. doi: 10.1007/s00415-014-7610-6. Epub 2014 Dec 12. No abstract available.

PMID:
25504308
35.

The overlap between vascular disease and Alzheimer's disease--lessons from pathology.

Attems J, Jellinger KA.

BMC Med. 2014 Nov 11;12:206. doi: 10.1186/s12916-014-0206-2. Review.

36.

Primary age-related tauopathy (PART): a common pathology associated with human aging.

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT.

Acta Neuropathol. 2014 Dec;128(6):755-66. doi: 10.1007/s00401-014-1349-0. Epub 2014 Oct 28.

37.

Pathogenesis of mild parkinsonian signs in aging.

Jellinger KA.

J Neurol. 2015 Jan;262(1):213. doi: 10.1007/s00415-014-7546-x. Epub 2014 Oct 28. No abstract available.

PMID:
25346065
38.

Neuropathology of multiple system atrophy: new thoughts about pathogenesis.

Jellinger KA.

Mov Disord. 2014 Dec;29(14):1720-41. doi: 10.1002/mds.26052. Epub 2014 Oct 9. Review.

PMID:
25297524
39.

Challenges of multimorbidity of the aging brain: a critical update.

Jellinger KA, Attems J.

J Neural Transm (Vienna). 2015 Apr;122(4):505-21. doi: 10.1007/s00702-014-1288-x. Epub 2014 Aug 5. Review.

PMID:
25091618
40.

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies.

Krismer F, Jellinger KA, Scholz SW, Seppi K, Stefanova N, Antonini A, Poewe W, Wenning GK.

Parkinsonism Relat Disord. 2014 Aug;20(8):793-9. doi: 10.1016/j.parkreldis.2014.05.005. Epub 2014 May 21. Review.

41.

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32. eCollection 2014. Erratum in: Am J Neurodegener Dis. 2015;4(2):49.

42.

Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.

Sachdev P, Kalaria R, O'Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P; Internationlal Society for Vascular Behavioral and Cognitive Disorders.

Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18. doi: 10.1097/WAD.0000000000000034.

43.

Towards translational therapies for multiple system atrophy.

Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, Wenning GK.

Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2. Review.

44.

Is there cerebellar pathology in essential tremor?

Jellinger KA.

Mov Disord. 2014 Apr;29(4):435-6. doi: 10.1002/mds.25852. Epub 2014 Mar 1. No abstract available.

PMID:
24585416
45.

Olfactory bulb involvement in neurodegenerative diseases.

Attems J, Walker L, Jellinger KA.

Acta Neuropathol. 2014 Apr;127(4):459-75. doi: 10.1007/s00401-014-1261-7. Epub 2014 Feb 20. Review.

PMID:
24554308
46.

The pathomechanisms underlying Parkinson's disease.

Jellinger KA.

Expert Rev Neurother. 2014 Feb;14(2):199-215. doi: 10.1586/14737175.2014.877842. Review.

PMID:
24471711
47.

The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.

Jellinger KA.

Int Rev Neurobiol. 2013;110:1-47. doi: 10.1016/B978-0-12-410502-7.00002-8. Review.

PMID:
24209432
48.

Amyloid and tau: neither chicken nor egg but two partners in crime!

Attems J, Jellinger KA.

Acta Neuropathol. 2013 Oct;126(4):619-21. doi: 10.1007/s00401-013-1167-9. Epub 2013 Aug 18. No abstract available.

PMID:
23955601
49.

Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease.

Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA.

Acta Neuropathol. 2013 Aug;126(2):161-77. doi: 10.1007/s00401-013-1154-1. Epub 2013 Jul 18. Review.

50.

Neuropathology of prolonged unresponsive wakefulness syndrome after blunt head injury: review of 100 post-mortem cases.

Jellinger KA.

Brain Inj. 2013;27(7-8):917-23. doi: 10.3109/02699052.2013.793395. Epub 2013 Jun 12.

PMID:
23758492

Supplemental Content

Loading ...
Support Center